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LETTERS TO EDITOR 
not perform the act. Another issue that needs 
discussion is the link between OCD and 
schizophrenia. Although OC symptoms are 
documented in association with schizophrenia 
(Rosen, 1957; Fenton and McGlashan,1986; 
Berman et al.,1995), phenomenological 
characteristics of OC phenomena that may 
predict the onset of schizophrenia is largely 
unknown. The onset of schizophrenic signs within 
two years of beginning of OCD of our patient, who 
had a rare compulsion, however, suggests the 
possibility that onset of rare compulsive 
phenomena may be a forerunner of schizophrenia. 
This issue has to be explored in future studies 
comprising patients who have uncommon 
compulsive phenomena. 
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CLOMIPRAMINE-INDUCED AFFECTIVE 
PSYCHOSIS AND COPROLALIA IN TOURETTE 
SYNDROME 
Sir, 
In comparison to obsessive-compulsive 
disorder (OCD), attention deficit-hyperactivity 
disorder (ADHD), depression and self-injurious 
behaviour, association of psychosis, especially 
manic psychosis with Tourette syndrome (TS) is 
less well-studied (Bleich etal., 1985). Moreover, 
antidepressant-induced manic psychosis has not 
been alluded in the literature on association of 
bipolardisorderandTS(Kerbeshianetal., 1995; 
Berthier et al., 1998). A case of clomipramine-
induced mania in a patient of TS presenting with 
exacerbationof tics and emergence of coprolalia 
is described. 
MM, an 18-year-old male, was diagnosed 
with TS at the age of nine years. Over these years, 
he developed motor tics (simple and complex) as 
well as simple vocal tics. There was no evidence 
of any coprophenomena until the present 
exacerbation. He was initially treated with pimozide 
for five years and discontinued the medicine when 
the tics were substantially decreased. However, 
on stopping the drug, the tics re-emerged, albeit 
with a milder intensity. Family history revealed 
chronic motor tic disorder in father and obsessive-
compulsive behaviour in mother and brother. On 
his part, patient never displayed any obsessive-
compulsive behaviour but premorbidly was 
described as being hyperactive. 
A month before the patient's referral, he was 
observed to be remaining aloof, appeared sad 
with occasiona'l crying spells, was less interested 
in studies and expressed hopelessness and 
worthlessness. Diagnosing him with a mild 
depressive episode, a general practitioner 
prescribed him clomipramine, which was titrated 
up to 75 mg/day. Two weeks after starting 
clomipramine, the patient became more talkative, 
started remaining cheerful and his sleep 
decreased. His condition gradually deteriorated 
so that at the time of presentation he had marked 
hyperactivity, aggressive behaviour, pressure of 
speech, flight of ideas, grandiose delusions and 
auditory hallucinations. In addition, his tics had 
worsened considerably and presently he had 
developed de novo coprolalia. He was initially 
treated with parenteral haloperidol and lorazepam 
and later valproate at 800 mg/day was added. His 
manic symptoms subsided but the coprolalia 
persisted in a milder form. 
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This case illustrates medication-induced 
affective psychosis in a patient with TS. 
Psychosis per se is a rare presentation in TS and 
that induced by antidepressants has not been 
documented. The antidepressant-induced manic 
psychosis was associated with worsening of 
existing tics, which is similar to previous reports 
(Berthier et al., 1998). Though clomipramine has 
been associated with exacerbation of tics (Kumar 
&Lang, 1997), emergence of new-onset coprolalia 
due to antidepressants has only been anecdotally 
cited (Delgado etal., 1990). Such an observation 
encourages further exploration of the role of 
antidepressant-induced cycling as a course 
modifier in TS. 
Another point that needs to be addressed 
is whether there is a subgroup of TS patients who 
are prone for bipolarity. A study showed that the 
risk of bipolar disorder in a group of patients with 
TS is at least four times greater than would be 
expected by chance (Kerbeshian et al., 1995). 
I The defining characteristics of this sub-group of 
patients include male adolescents who have mild 
tics and comorbid psychiatric diagnoses (Berthier 
et al., 1998). Our patient had all these 
characteristics and thus it could be argued that 
his propensity for bipolarity was unmasked by the 
antidepressant. Hence, through this report authors 
emphasize exercising caution while prescribing 
antidepressants to such patients of TS as defined 
above. This is pertinent to cases of TS with 
comorbid OCD wherein antidepressants are 
prescribed to treat the latter condition. Use of 
antidepressants with a lesser potential for causing 
a manic switch such as selective serotonin 
reuptake inhibitors or concurrent use of mood 
stabilizers can be explored in a similar situation. 
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* Correponcfence. 
RESEARCH IN INDIA: NOT GOOD ENOUGH? 
Sir, 
At the recent Mid-Term National CME of 
the Indian Psychiatric Society in Nagpur, two 
lectures caught my attention. One lecture aimed 
to provide a review of the research on 
schizophrenia from India. The review was very 
comprehensive and systematic. The speaker 
concluded that, despite the large volume of work, 
the majority of research was poor in design, had 
limited value as evidence for practice, and lacked 
originality. The second lecture, by the editor of 
this journal, was on the evidence base for the 
treatment for schizophrenia It was notable, as a 
member of the audience remarked, that not a 
single Indian study was cited in the evidence base. 
Not surprisingly, we were informed that no Indian 
study made the required mark to be considered 
as good enough evidence for the treatment of 
schizophrenia. Not a SINGLE Indian study! This 
is remarkable given that India has one of the largest 
number of psychiatrists in teaching or academic 
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